Andrew Joseph Muir, MD

Professor of Medicine
Chief, Division of Gastroenterology in the Department of Medicine
Member in the Duke Clinical Research Institute
Campus mail 03137B Hosp South, Durham, NC 27710
Phone (919) 684-2052
Email address andrew.muir@duke.edu
  • Hepatitis C 
  • Primary sclerosing cholangitis
  • Cirrhosis
  • Liver Transplantation
  • Clinical Trials
  • Healthcare disparities in liver disease 
  • Outcomes Research

Education and Training

  • Fellow in Gastroenterology, Medicine, Duke University, 1998 - 2000
  • Chief Medical Resident, Medicine, Duke University, 1997 - 1998
  • Fellow in Gastroenterology, Medicine, Duke University, 1996 - 1997
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2001
  • M.D., Duke University, 1993

Publications

Bailey, Donald E., Andrew J. Muir, Michael P. Cary, Natalie Ammarell, Sarah Seaver, Emily Scirica, Mitch Mah’moud, and Ruth A. Anderson. “Adaptive Challenges and Family Support: Patient Self-Management during Treatment for Chronic Hepatitis C.” Nurs Sci Q 34, no. 4 (October 2021): 405–12. https://doi.org/10.1177/08943184211031602.

PMID
34538181
Full Text

Patel, Yuval A., Jia Yao, Rae Jean Proeschold-Bell, Donna Niedzwiecki, Elizabeth Goacher, and Andrew J. Muir. “Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.” Dig Dis Sci 66, no. 9 (September 2021): 2956–63. https://doi.org/10.1007/s10620-020-06616-5.

PMID
32968965
Full Text

Dai, Rui, Alan A. Sag, Jonathan G. Martin, Nicholas T. Befera, Waleska M. Pabon-Ramos, Paul V. Suhocki, Tony P. Smith, Charles Y. Kim, Andrew J. Muir, and James Ronald. “Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.” Clin Imaging 77 (September 2021): 187–92. https://doi.org/10.1016/j.clinimag.2021.04.034.

PMID
33940357
Full Text

Sulkowski, Mark S., Juhi S. Moon, Kenneth E. Sherman, Giuseppe Morelli, Jama M. Darling, Andrew J. Muir, Mandana Khalili, et al. “A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.” Hepatology, July 13, 2021. https://doi.org/10.1002/hep.32053.

PMID
34255381
Full Text

Helzberg, James H., Rui Dai, Andrew J. Muir, Julius Wilder, Tzu-Hao Lee, Jonathan G. Martin, Charles Y. Kim, and James Ronald. “Socioeconomic Status Is Associated with the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation.” J Vasc Interv Radiol 32, no. 7 (July 2021): 950-960.e1. https://doi.org/10.1016/j.jvir.2020.11.022.

PMID
33663923
Full Text

Cooper, Stewart L., Wendy C. King, Douglas B. Mogul, Marc G. Ghany, Kathleen B. Schwarz, and Kathleen B. Hepatitis B Research Network (HBRN). “Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.” Journal of Viral Hepatitis 28, no. 7 (July 2021): 1042–56. https://doi.org/10.1111/jvh.13520.

PMID
33893706
Full Text

Trivedi, Palak J., Andrew J. Muir, Cynthia Levy, Christopher L. Bowlus, Michael P. Manns, Xiaomin Lu, Gerald Crans, et al. “Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.” Clin Gastroenterol Hepatol 19, no. 6 (June 2021): 1248–57. https://doi.org/10.1016/j.cgh.2020.07.032.

PMID
32707342
Full Text

Jiang, Hanyu, Bin Song, Yun Qin, Jie Chen, Dong Xiao, Hong Ii Ha, Xijiao Liu, et al. “Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.” Eur Radiol 31, no. 6 (June 2021): 3638–48. https://doi.org/10.1007/s00330-020-07488-z.

PMID
33245494
Full Text

Wilder, Julius M., Donna M. Evon, Rae Jean Proeschold-Bell, Jia Yao, Malik Muhammed Sohail, Donna Niedzwiecki, Christina Makarushka, Terra Hodge, and Andrew J. Muir. “Why do patients with chronic hepatitis C drink alcohol? An examination of pain, depression and drinking motives.” J Viral Hepat 28, no. 5 (May 2021): 699–709. https://doi.org/10.1111/jvh.13474.

PMID
33476429
Full Text

Gindin, Yevgeniy, Chuhan Chung, Zhaoshi Jiang, Jing Zhu Zhou, Jun Xu, Andrew N. Billin, Robert P. Myers, et al. “A Fibrosis-Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis.” Hepatology (Baltimore, Md.) 73, no. 3 (March 2021): 1105–16. https://doi.org/10.1002/hep.31488.

PMID
32745270
Full Text

Pages